Stocks · News reference
HUM stock drops premarket: Humana beats Q2 estimates, but fails to impress as industry peers raise expectations.
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Launched July 1, this partnership builds on the organizations' long-standing collaboration in end stage kidney disease and expands earlier into the disease journey, when intervention can have the greatest impact.As
Read original at benzingaMark Cuban is urging funds to divest from major health insurers. Here’s how broad-market ETFs remain exposed to the companies he’s targeting.
Read original at benzingaMark Cuban urged investors to pressure health insurers over healthcare costs, calling for funds to divest their stakes.
Read original at benzingaJP Morgan analyst Lisa Gill maintains Humana (NYSE:HUM) with a Neutral and raises the price target from $316 to $393.
Read original at benzingaCigna Healthcare is introducing Smart Coverage, a new benefit option that automatically links medical claims with supplemental benefits to provide eligible members up to $7,000 for covered health events. The program launches January 1, 2027, for mid-sized employers and addresses a significant affordability gap, with nearly 60% of Americans unprepared for health costs. The initiative is designed to increase enrollment in high-deductible plans and boost supplemental product participation.
Read original at zacks-investment-researchShares of UnitedHealth are trading higher Wednesday afternoon. Here's what investors need to know.
Read original at benzinga